Early-Onset Digestive System Cancers: Risk Factors and Clinicopathological and Molecular Features Across Organ Sites.

This review article examines the rising incidence of early-onset digestive system cancers (diagnosed before age 50), including esophageal, gastric, colorectal, liver, extrahepatic bile duct, gallbladder, and pancreatic cancers.

Key points:

• Epidemiology: The incidence of these cancers is increasing across multiple regions, contrasting with stable or declining rates in older adults for some sites (especially colorectum). The trend appears organ-specific but collectively signals a growing burden in younger populations.
• Risk factors: The authors synthesize available evidence on potential contributors such as lifestyle (dietary patterns, obesity, physical inactivity, alcohol, tobacco), metabolic and inflammatory conditions, infections (e.g., H. pylori, viral hepatitis), genetic susceptibility, and possibly early-life and environmental exposures. They emphasize that data are incomplete, particularly for several upper GI and hepatobiliary sites.
• Clinical and pathological features: Early-onset cases often present at more advanced stages and may show distinct clinicopathologic characteristics compared with later-onset cancers, although patterns vary by organ site. The review notes both shared themes (e.g., delayed diagnosis, more aggressive presentation) and site-specific differences.
• Molecular characteristics: Limited but emerging data suggest that early-onset tumors can have different molecular profiles from typical later-onset counterparts, with variation by organ site. The authors underline the need for more comprehensive genomic, epigenetic, and tumor microenvironment studies in younger patients.
• Implications and research gaps: The review highlights:
  • The need to clarify causal pathways and modifiable risk factors specific to early-onset disease.
  • Opportunities to refine prevention (e.g., targeted lifestyle and infection control strategies), screening and earlier detection (including risk-adapted approaches), and therapeutic strategies tailored to younger patients’ biology and clinical context.
  • The importance of integrating epidemiologic, clinical, and molecular data, ideally in large, diverse cohorts, to better understand and respond to this rising trend.

Overall, the article serves as a synthesis of current knowledge and a roadmap for future research to address the increasing burden of early-onset digestive system cancers.